The primary goal of genetic engineering in the context of human enhancement is to improve physical and cognitive abilities, such as intelligence, athleticism, and resistance to disease.

CRISPR-Cas9 is a gene-editing technology that allows scientists to precisely target and modify DNA sequences. It has revolutionized the field of genetic engineering due to its simplicity, efficiency, and versatility.

Genetic engineering has the potential to cure genetic diseases, enhance physical and cognitive abilities, and increase lifespan by modifying genes responsible for these traits.

Genetic engineering and human enhancement raise ethical concerns such as creating a divide between the genetically enhanced and the natural, unintended consequences and unforeseen risks, and access to genetic enhancements only for the wealthy.

The term 'designer babies' is used to describe the creation of genetically modified babies with specific traits or characteristics chosen by their parents.

China was the first country to allow clinical trials for gene editing in human embryos in 2015.

Genetic engineering has the potential to accelerate human evolution by allowing scientists to introduce beneficial genetic changes that would normally take thousands or millions of years to occur naturally.

Human enhancement is the term used to describe the use of genetic engineering to enhance human traits beyond what is considered normal.

Autonomy is the ethical principle that emphasizes the importance of respecting individual autonomy and the right to make choices about one's own body.

The Brave New World argument is the term used to describe the slippery slope argument against genetic engineering and human enhancement, which suggests that once we start down the path of genetic modification, it will be difficult to control and could lead to unintended consequences.

UNESCO has established guidelines for the ethical use of genetic engineering and human enhancement through its Universal Declaration on the Human Genome and Human Rights.

Posthumanism is the term used to describe the idea of using genetic engineering to create a new species of humans with enhanced abilities.

Non-maleficence is the ethical principle that emphasizes the importance of doing no harm.

Genetic therapy is the term used to describe the idea of using genetic engineering to eliminate genetic diseases and disabilities.

Justice is the ethical principle that emphasizes the importance of fairness and equity in the distribution of benefits and burdens.